Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies-Reference-Cited by-同舟云学术

Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies

Published:2022-08 Issue: Volume:170 Page:41-51
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Johnson Melissa,Garassino Marina Chiara,Mok Tony,Mitsudomi Tetsuya

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference121 articles.

1. J. Greenhalgh, K. Dwan, A. Boland, V. Bates, F. Vecchio, Y. Dundar, P. Jain, J.A. Green, First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer, Cochrane Database Syst Rev (5) (2016) Cd010383.

2. Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort;Lau;Clin Lung Cancer,2019

3. Overview of the LUX-Lung clinical trial program of afatinib for non-small cell lung cancer;Sharma;Cancer Treat. Rev.,2018

4. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis;Zhang;Oncotarget,2016

5. Analysis of progression-free survival of first-line tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring leu858Arg or exon 19 deletions;Kuan;Oncotarget,2017

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schisandrin C inhibits AKT1-regulated cell proliferation in A549 cells;International Immunopharmacology;2024-12

2. Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy;European Journal of Pharmacology;2024-10

3. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors;Future Medicinal Chemistry;2024-08-29

4. Dual inhibition of EGFR and PI3K with a single drug;Nature Cancer;2024-08-16

5. Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants;Molecular Diagnosis & Therapy;2024-08-02